Loading...
Chemical structure of LNP023

GC36472

LNP023

Also known as 4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl]benzoic acid

LNP023 (LNP023) is a first-in-class, orally bioavailable, highly potent and highly selective factor B inhibitor with an IC50 value of 10 nM

ChemicalCAS1644670-37-0MW422.52FormulaC25H30N2O4
CAS number
1644670-37-0
Molecular weight
422.52
Formula
C25H30N2O4
Solubility
DMSO： 200 mg/mL (473·35 mM)
InChIKey
RENRQMCACQEWFC-UGKGYDQZSA-N
Catalogue number
GC36472
Brand
GLPBIO
Computed properties PubChem CID 90467622 · XLogP 1.8 · TPSA 74.8 Ų · H-bond donors 2
XLogP
1.8
TPSA
74.8 Ų
H-bond donors
2
H-bond acceptors
5
Rotatable bonds
7
Heavy atoms
31

SMILES CCO[C@H]1CCN([C@@H](C1)C2=CC=C(C=C2)C(=O)O)CC3=C(C=C(C4=C3C=CN4)C)OC

Computed descriptors from PubChem (CID 90467622), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.

Ordering in Israel

Lead time
Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
Pricing
Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
Documents
Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
Who we serve
Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.